These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8843630)

  • 1. Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100.
    Idänpään-Heikkilä I; Wahlström E; Muttilainen S; Nurminen M; Käyhty H; Sarvas M; Mäkelä PH
    Vaccine; 1996 Jun; 14(9):886-91. PubMed ID: 8843630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The class 1 outer membrane protein of Neisseria meningitidis produced in Bacillus subtilis can give rise to protective immunity.
    Nurminen M; Butcher S; Idänpään-Heikkilä I; Wahlström E; Muttilainen S; Runeberg-Nyman K; Sarvas M; Mäkelä PH
    Mol Microbiol; 1992 Sep; 6(17):2499-506. PubMed ID: 1406285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis.
    Idänpään-Heikkilä I; Muttilainen S; Wahlström E; Saarinen L; Leinonen M; Sarvas M; Mäkelä PH
    Vaccine; 1995 Nov; 13(16):1501-8. PubMed ID: 8578833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis and reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes.
    Muttilainen S; Idänpään-Heikkilä I; Wahlström E; Nurminen M; Mäkelä PH; Sarvas M
    Microb Pathog; 1995 Jun; 18(6):423-36. PubMed ID: 8551945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of meningococcal outer membrane protein vaccines solubilized with detergent or C polysaccharide.
    Poolman JT; Timmermans HA; Hopman CT; Teerlink T; Van Vught PA; Witvliet MH; Beuvery EC
    Antonie Van Leeuwenhoek; 1987; 53(6):413-9. PubMed ID: 3130780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class 1/3 outer membrane protein vaccine against group B, type 15, subtype 16 meningococci.
    Poolman JT; Beuvery EC; Hopman CT; Witvliet MH; Timmermans HA; Teerlink T; Zanen HC
    Dev Biol Stand; 1986; 63():147-52. PubMed ID: 3091433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci.
    Christodoulides M; Brooks JL; Rattue E; Heckels JE
    Microbiology (Reading); 1998 Nov; 144 ( Pt 11)():3027-3037. PubMed ID: 9846738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci.
    Jolley KA; Appleby L; Wright JC; Christodoulides M; Heckels JE
    Infect Immun; 2001 Jun; 69(6):3809-16. PubMed ID: 11349046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein.
    Van Der Ley P; Poolman JT
    Infect Immun; 1992 Aug; 60(8):3156-61. PubMed ID: 1639486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody studies in mice of outer membrane antigens for use in an improved meningococcal B and C vaccine.
    Milagres LG; Cristina M; Brandileone MC; Sacchi CT; Vieira VS; Zanella RC; Frasch CE
    FEMS Immunol Med Microbiol; 1996 Jan; 13(1):9-17. PubMed ID: 8821393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody production to a meningococcal outer membrane protein cloned into liv Salmonella typhimurium aroA vaccine strain.
    Tarkka E; Muotiala A; Karvonen M; Saukkonen-Laitinen K; Sarvas M
    Microb Pathog; 1989 May; 6(5):327-35. PubMed ID: 2505011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine.
    Naess LM; Aarvak T; Aase A; Oftung F; Høiby EA; Sandin R; Michaelsen TE
    Vaccine; 1999 Feb; 17(7-8):754-64. PubMed ID: 10067680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human bactericidal antibody response to meningococcal outer membrane protein vaccines.
    Zollinger WD; Boslego J; Frøholm LO; Ray JS; Moran EE; Brandt BL
    Antonie Van Leeuwenhoek; 1987; 53(6):403-11. PubMed ID: 3130779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
    Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous production of the P1 porin of Neisseria meningitidis in bacillus subtilis: the effect of an N-terminal extension on the presentation of native-like epitopes.
    Muttilainen S; Butcher SJ; Runeberg K; Nurminen M; Idänpään-Heikkilä I; Wahlström E; Sarvas M
    Microb Pathog; 1995 May; 18(5):365-71. PubMed ID: 7476101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide.
    Christodoulides M; McGuinness BT; Heckels JE
    J Gen Microbiol; 1993 Aug; 139(8):1729-38. PubMed ID: 7691983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease.
    Idänpään-Heikkilä I; Høiby EA; Chattopadhyay P; Airaksinen U; Michaelsen TM; Wedege E
    J Med Microbiol; 1995 Nov; 43(5):335-43. PubMed ID: 7562997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of IgG subclass antibody responses after immunization with a group B meningococcal outer membrane vesicle vaccine, using monoclonal mouse-human chimeric antibodies as standards.
    Naess LM; Rosenqvist E; Høiby EA; Michaelsen TE
    J Immunol Methods; 1996 Sep; 196(1):41-9. PubMed ID: 8841442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonophagocytic and bactericidal activity mediated by purified IgG subclass antibodies after vaccination with the Norwegian group B meningococcal vaccine.
    Aase A; Høiby EA; Michaelsen TE
    Scand J Immunol; 1998 Apr; 47(4):388-96. PubMed ID: 9600322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.